Literature DB >> 20488350

Superior vena cava syndrome.

Jonathan F Wan1, Andrea Bezjak.   

Abstract

Superior vena cava syndrome is a common complication of malignancy. The epidemiology, presentation, and diagnostic evaluation of patients presenting with the syndrome are reviewed. Management options including chemotherapy and radiation therapy and the role of endovascular stents are discussed along with the evidence for each of the therapeutic options. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID: 20488350     DOI: 10.1016/j.hoc.2010.03.003

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  10 in total

1.  Endovascular management of chronic upper extremity deep vein thrombosis and superior vena cava syndrome.

Authors:  Patrick Warren; Charles Burke
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

2.  Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome : A single-center retrospective analysis of 21 years' practice.

Authors:  Manuel Guhlich; Teresa Esther Maag; Leif Hendrik Dröge; Rami A El Shafie; Andrea Hille; Sandra Donath; Markus Anton Schirmer; Olga Knaus; Friedemann Nauck; Tobias Raphael Overbeck; Marc Hinterthaner; Wolfgang Körber; Stefan Andreas; Achim Rittmeyer; Martin Leu; Stefan Rieken
Journal:  Strahlenther Onkol       Date:  2022-05-12       Impact factor: 3.621

Review 3.  Superior Vena Cava Syndrome: Etiologies, Manifestations, and Treatments.

Authors:  Keith B Quencer
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

4.  Palliative treatment of superior vena cava syndrome with nitinol stents.

Authors:  Poul Erik Andersen; Stevo Duvnjak
Journal:  Int J Angiol       Date:  2014-12

5.  Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?

Authors:  Younghoon Cho; Dong Il Gwon; Gi-Young Ko; Heung Kyu Ko; Jin Hyoung Kim; Ji Hoon Shin; Hyun-Ki Yoon; Kyu-Bo Sung
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

6.  PEMBERTON'S SIGN AND INTENSE FACIAL EDEMA IN SUPERIOR VENA CAVA SYNDROME DUE TO RETROSTERNAL GOITER.

Authors:  C Giulea; O Enciu; M Nadragea; C Badiu; A Miron
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Apr-Jun       Impact factor: 0.877

Review 7.  Role of radiotherapy in metastatic non-small cell lung cancer.

Authors:  Sergio L Faria
Journal:  Front Oncol       Date:  2014-10-13       Impact factor: 6.244

8.  Congenital Absence of Superior Vena Cava with no Manifestation of Superior Vena Cava Syndrome.

Authors:  Chan Soon Park; Jeong Jae Kim; Jin Joo Park
Journal:  Korean Circ J       Date:  2016-09-28       Impact factor: 3.243

Review 9.  Malignant Superior Vena Cava Syndrome: State of the Art.

Authors:  Vasileios Patriarcheas; Maria Grammoustianou; Nikolaos Ptohis; Ioanna Thanou; Minas Kostis; Ioannis Gkiozos; Andriani Charpidou; Ioannis Trontzas; Nikolaos Syrigos; Elias Kotteas; Evangelos Dimakakos
Journal:  Cureus       Date:  2022-01-04

Review 10.  Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome.

Authors:  Christopher Straka; James Ying; Feng-Ming Kong; Christopher D Willey; Joseph Kaminski; D W Nathan Kim
Journal:  Springerplus       Date:  2016-02-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.